2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

de Thurah, Annette, Bosch, Philipp, Marques, Andrea, Meissner, Yvette, Mukhtyar, Chetan B. ORCID: https://orcid.org/0000-0002-9771-6667, Knitza, Johannes, Najm, Aurélie, Østerås, Nina, Pelle, Tim, Knudsen, Line Raunsbæk, Šmucrová, Hana, Berenbaum, Francis, Jani, Meghna, Geenen, Rinie, Krusche, Martin, Pchelnikova, Polina, de Souza, Savia, Badreh, Sara, Wiek, Dieter, Piantoni, Silvia, Gwinnutt, James M., Duftner, Christina, Canhão, Helena M., Quartuccio, Luca, Stoilov, Nikolay, Prior, Yeliz, Bijlsma, Johannes W. J., Zabotti, Alen, Stamm, Tanja A. and Dejaco, Christian (2022) 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 81 (8). pp. 1065-1071. ISSN 0003-4967

[thumbnail of Ptc for remote care_revision_v2_clean_NO-ts]
PDF (Ptc for remote care_revision_v2_clean_NO-ts) - Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (315kB) | Preview


Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is needed on the integration of telehealth into clinical care of people with rheumatic and musculoskeletal diseases (RMD).  Objective: To develop EULAR points to consider (PtC) for the development, prioritisation and implementation of telehealth for people with RMD.  Methods: A multidisciplinary EULAR task force (TF) of 30 members from 14 European countries was established, and the EULAR standardised operating procedures for development of PtC were followed. A systematic literature review was conducted to support the TF in formulating the PtC. The level of agreement among the TF was established by anonymous online voting.  Results: Four overarching principles and nine PtC were formulated. The use of telehealth should be tailored to patient's needs and preferences. The healthcare team should have adequate equipment and training and have telecommunication skills. Telehealth can be used in screening for RMD as preassessment in the referral process, for disease monitoring and regulation of medication dosages and in some non-pharmacological interventions. People with RMD should be offered training in using telehealth, and barriers should be resolved whenever possible. The level of agreement to each statement ranged from 8.5 to 9.8/10.  Conclusion :The PtC have identified areas where telehealth could improve quality of care and increase healthcare access. Knowing about drivers and barriers of telehealth is a prerequisite to successfully establish remote care approaches in rheumatologic clinical practice.

Item Type: Article
Additional Information: Funding Information: Funding MJ is funded by a National Institute for Health Research (NIHR) Advanced Fellowship [NIHR301413]. The project: ’Points to consider for remote care in rheumatic and musculoskeletal diseases (RMDs)’ was funded by the European Alliance of Association for Rheumatology (EULAR). Project number CLI124 Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.
Uncontrolled Keywords: epidemiology,health services research,patient care team,face-to-face,knee osteoarthritis,exercise management,physical-therapists,controlled-trial,service models,follow-up,telephone,health,arthritis,biochemistry, genetics and molecular biology(all),rheumatology,immunology and allergy,immunology ,/dk/atira/pure/subjectarea/asjc/1300
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 15 Jun 2022 11:31
Last Modified: 22 Oct 2022 18:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/85633
DOI: 10.1136/annrheumdis-2022-222341

Actions (login required)

View Item View Item